Navigation Links
Inverness Medical Innovations Announces Third Quarter 2008 Results
Date:10/29/2008

5,536)

Income tax (benefit)

provision (13,274) 71,050(j) 57,776

Equity earnings of

unconsolidated entities,

net of tax 1,169 6,678(b)( c ) 7,847

Net (loss) income $(38,181) $153,169 $114,988

Preferred stock dividends $(8,500) $(8,500)

Net (loss) income

available to common

stockholders - basic $(46,681) $106,488

Net (loss) income per common

share

Basic $(0.60) $1.37

Diluted $(0.60)(k) $1.30(l)

Weighted average common

shares - basic 77,630 77,630

Weighted average common

shares - diluted 77,630(k) 83,390(l)

Nine Months Ended September 30, 2007

Non-GAAP

Non-GAAP Adjusted Cash

GAAP Adjustments Basis(a)

Net revenue $551,580 $- $551,580

Cost of revenue 296,604 (21,611)(b)(d)(e) 274,993

Gross profit 254,976 21,611 276,587

Gross margin 46% 50%

Operating expenses:

Research and development 44,649 (3,759)(b)( c )(d) 40,890

Purchase of in-process

research and development 169,000 (169,000)(f) -

Selling, general and

administrative 224,008 (71,921)(b)( c )(d) 152,087

Total operating expenses 437,657 (244,680) 192,977

Operating income (loss)
'/>"/>

SOURCE Inverness Medical Innovations, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET October 29, 2008 to Discuss Third Quarter 2008 Results
2. Inverness Medical Innovations to Present at the UBS Global Life Sciences Conference on September 22, 2008
3. Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008
4. Inverness Medical Innovations Declares Dividend on its Series B Convertible Perpetual Preferred Stock
5. Inverness Medical Innovations to Present at the Morgan Stanley Global Healthcare Unplugged Conference on September 9, 2008
6. Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
7. Inverness Medical Innovations to Present at Canaccord Adams 28th Annual Growth Conference on August 12, 2008
8. Inverness Medical Innovations Announces Second Quarter 2008 Results
9. Inverness Medical Innovations to Present at Jefferies 2nd Annual Healthcare Conference held on June 25, 2008
10. Inverness Medical Innovations to Present at 7th Annual Needham & Company, LLC Biotechnology & Medical Technology Conference on June 12, 2008
11. Inverness Medical Innovations to Present at FBR Capital Markets 12th Annual Spring Investor Conference on May 28, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... May 17, 2013  Cellular Biomedicine Group (OTCQB: ... enrollment of the total projected enrollment required for ... and preliminary efficacy of the medical technology haMPC ... Osteoarthritis (KOA). To date the trial has had ... The Phase I open label clinical research trial ...
(Date:5/17/2013)... Toronto, Canada (PRWEB) May 17, 2013 ... to understanding complex biological systems that can help predict ... Keynote speaker Dr. Sergey Stepaniants, Head of Computational Biology ... of computational biology tools to ensure high-quality genomics when ... tools can be applied to complex data sets to ...
(Date:5/16/2013)... The Stirling Ultracold Model SU780U ultra-low ... USA, won the Outstanding New Product Award presented on ... and Environmental Repositories (ISBER) at their annual meeting in ... recognizes the company’s development and introduction of the world’s ... was presented to Global Cooling’s CEO Neill Lane by ...
(Date:5/16/2013)... Needham, Mass. (PRWEB) May 16, 2013 ... Bioprocessing Summit from August 19-23, 2013 at the Renaissance ... comprising the Summit provide a close-up look at the ... risk and ensuring bottom-line quality. Leaders in the ... innovative ways to produce biopharmaceuticals with greater specificity and ...
Breaking Biology Technology:Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference, Sydney, Australia 2The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2
... GLENDALE, Calif., April 3 Immunotech Laboratories (Pink ... in setting up a potential venture for South ... Ghanime, Chairman of Immunotech Laboratories, the potential outcome ... for its preclinical activities and position the company ...
... Partner to Co-Develop Company,s Chinese Patented Skeletal Muscle ... Sinobiopharma, Inc. (OTC ... to announce that it has signed ... organization headquartered in New Jersey that specializes in ...
... -- China Agri-Business, Inc.,(OTC Bulletin Board: CHBU) a ... company in China, announced its,financial results for the ... Revenue for the year ended December 31, ... to $3,037,414 for the year ended December 31,2007. ...
Cached Biology Technology:Immunotech Laboratories Announces South American Strategy 2Sinobiopharma Signs Export Agreement With U.S. Pharmaceutical Supplier 2China Agri-Business Announces 2008 Operating Results 2China Agri-Business Announces 2008 Operating Results 3China Agri-Business Announces 2008 Operating Results 4China Agri-Business Announces 2008 Operating Results 5
(Date:5/16/2013)... pulses outside of the gym. But doctors use the human ... Zhenan Bao, a professor of chemical engineering at Stanford, has ... no wider than a postage stamp. The flexible skin-like monitor, ... enough to help doctors detect stiff arteries and cardiovascular problems. ... track heart health and provide doctors a safer method of ...
(Date:5/15/2013)... touting its benefit in moderating gout risk, new research ... not reduce uric acid (urate) levels to a clinically ... supplementation, alone or in combination with allopurinol, appears to ... in gout patients according to the results published in ... & Rheumatism . , Gout is an inflammatory ...
(Date:5/15/2013)... To reach Canada,s goal of reducing greenhouse gas (GHG) ... by the year 2020, federal and provincial governments, led ... agreement on what portion of the total GHG reduction ... the University of Toronto,s School of the Environment. ... and provincial governments, opposition parties and other participants in ...
Breaking Biology News(10 mins):Stanford engineers monitor heart health using paper-thin flexible 'skin' 2Stanford engineers monitor heart health using paper-thin flexible 'skin' 3Vitamin C does not lower uric acid levels in gout patients 2Canada must addess real climate-change challenge 2Canada must addess real climate-change challenge 3
... fussy housekeeper isn’t such a good thing after all. ... Cincinnati (UC) say they have confirmed what other scientists ... components (molecules) can help build stronger immune systems, and ... team found that infants who were exposed to high ...
... skull-splitting pain. Scientists have found evidence that the headaches ... parts of the brain starved for oxygen and altering ... the work by neuroscientists at the University of Rochester ... , The scientists say the work makes it ...
... new study appearing in the May issue of The ... geologists must account for when examining dinosaur tracks. The ... family of dinosaurs that includes the T. Rex and ... effects of many different types of erosion on these ...
Cached Biology News:Early exposure to indoor fungus molecules may protect infants against future allergies 2Mice with a migraine show signs of brain damage 2Mice with a migraine show signs of brain damage 3Mice with a migraine show signs of brain damage 4Mice with a migraine show signs of brain damage 5How to look at dinosaur tracks 2
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
... siRNA service provides the premium quality siRNAs ... Custom siRNAs can be readily ordered online ... sequence, or by providing the sense and ... Silencer Validated and Silencer ...
Recombinant Ovine (Sheep) Prolactin, Ultra Pure...
Human SCP3 Affinity Purified Polyclonal Ab Keywords: Spermatogenesis, meiosis Protein Family: Cell Cycle...
Biology Products: